Unitree Robotics has received regulatory approval to proceed with one of the most closely watched technology listings in China.
The China Securities Regulatory Commission approved the company’s application to launch an initial public offering on the Shanghai Stock Exchange’s STAR Market, a board created for science and technology companies.
Unitree intends to raise approximately 4.2 billion yuan, equivalent to about $619 million at the exchange rate used when the approval was announced. The Hangzhou-based robot manufacturer plans to issue at least 40.45 million new shares.
The approval brings Unitree considerably closer to becoming a publicly traded company, but the IPO has not yet launched. Unitree has not announced a final offering price, subscription date or first day of trading.
Unitree Clears a Major Regulatory Hurdle
China’s securities regulator approved Unitree’s IPO registration after reviewing the listing opinion submitted by the Shanghai Stock Exchange and the company’s registration documents.
The regulatory approval remains valid for 12 months. Unitree must complete the offering within that period unless it obtains an extension or submits a new application.
The decision follows a relatively rapid review process.
The Shanghai Stock Exchange formally accepted Unitree’s application on March 20, 2026. The company subsequently responded to two rounds of pre-review questions before the exchange’s Listing Review Committee examined the application in June.
Receiving registration approval means that Unitree has cleared one of the most important regulatory stages of the process. It does not mean that the company’s shares are already available to investors.
The final timetable will depend on the company, its underwriters and prevailing market conditions.
What the $619 Million Offering Includes
Unitree plans to issue no fewer than 40.4464 million new shares and raise approximately 4.202 billion yuan.
The final number of shares and the amount raised could change once the company determines the offering price. Unitree had not published a price range or confirmed a launch date when the approval was announced.
The shares are expected to trade on the STAR Market, officially known as the Science and Technology Innovation Board of the Shanghai Stock Exchange.
The market was designed to support companies operating in areas such as artificial intelligence, advanced manufacturing, semiconductors, biotechnology and other strategically important technologies.
Unitree’s listing would give public-market investors direct exposure to a company whose business spans humanoid robots, quadruped robots, robotic components and embodied artificial intelligence.
If completed, the flotation could also make Unitree the first specialist humanoid robot manufacturer listed on mainland China’s A-share market. That description does not include companies such as UBTech Robotics, which is listed separately in Hong Kong.
Where Unitree Plans to Spend the Money
Unitree has identified four principal areas for the IPO proceeds:
- Research and development of artificial intelligence models for intelligent robots.
- Research into robot bodies and core robotic systems.
- Development of new intelligent robot products.
- Construction of a smart robot manufacturing base.
The investments are intended to address both sides of the humanoid robotics problem: the physical machine and the intelligence required to control it.
The robot-body research programme will support improvements to movement, balance, manipulation, components and mechanical design. The AI programme is expected to focus on models capable of connecting perception, decision-making and physical actions.
Unitree also wants to increase its manufacturing capacity as demand for models such as the Unitree G1 expands beyond specialist research laboratories.
This division of spending is significant. Humanoid robot manufacturers are no longer competing solely on whether their machines can walk, run or reproduce a choreographed demonstration.
The larger challenge is developing robots that can understand their surroundings, learn useful tasks and perform them reliably enough to justify their cost.
Image Credits: Asia Tech LensFrom Robot Dogs to Humanoid Robots
Unitree was founded in Hangzhou in 2016 by robotics engineer Wang Xingxing.
The company initially became known for producing relatively affordable quadruped robots. Its machines offered universities, developers and businesses an alternative to considerably more expensive platforms from established international robotics companies.
That product strategy helped Unitree build a global position in the robot dog market.
Its current quadruped range includes models designed for research, education, development and industrial applications. Anton Robots currently lists machines such as the Unitree Go2 Pro and the industrial Unitree B2.
Unitree later transferred its experience in motors, control systems, balance and legged locomotion into humanoid development.
The company introduced the H1 humanoid in 2023, followed by the smaller G1 in 2024. More recent additions have expanded Unitree’s range across different sizes, prices and intended applications.
Unitree says it develops important elements of its robotics stack internally, including motors, reducers, controllers, lidar systems and motion-control algorithms. This vertical integration has helped the company reduce costs and bring products to market at prices below many competing humanoid platforms.
Humanoids Have Become Unitree’s Main Growth Engine
Unitree’s business was originally dominated by quadruped robots, but its revenue mix changed rapidly after the introduction of its humanoid platforms.
Humanoid robots represented approximately 27.6% of Unitree’s principal business revenue in 2024. Their share rose to 51.5% during the first nine months of 2025, according to figures disclosed in the company’s IPO documents.
Unitree said it shipped more than 5,500 humanoid robots in 2025. Its prospectus estimated that this represented approximately 32.4% of global humanoid shipments for the year.
The Unitree G1 has been central to that expansion.
The relatively compact humanoid was designed as an accessible platform for universities, AI laboratories, robotics developers and companies experimenting with embodied intelligence. Its lower price compared with many competing humanoids has allowed more organizations to obtain physical platforms for testing.
Unitree’s more advanced humanoid range also includes the Unitree H2, which targets buyers seeking a larger and more capable platform.
The company’s visibility has been reinforced by public demonstrations involving dancing, running, boxing and martial arts. These performances have helped establish the Unitree name internationally, although they do not necessarily represent the autonomous capabilities available to commercial customers.
The Financial Performance Behind the IPO
Unitree’s rapid revenue growth is one of the central arguments supporting the listing.
The company generated approximately 1.7 billion yuan in revenue during 2025, compared with around 392 million yuan in 2024. That represented annual growth of more than 330%.
Unitree reported attributable net profit of approximately 287.6 million yuan for 2025.
Its profit after excluding non-recurring gains and losses was significantly higher, at approximately 600 million yuan. The difference was largely associated with a non-cash share-based compensation charge connected to an employee incentive programme.
The company’s core-business gross margin was approximately 60% during the year, an unusually high figure for a hardware manufacturer.
Unitree’s financial performance reflects a combination of rising demand, relatively high product margins and its ability to develop many components internally.
However, the pace of profit growth may become harder to maintain.
Unitree reported first-quarter 2026 revenue of approximately 423 million yuan, an increase of about 68% from the previous year. Adjusted net profit fell to around 40 million yuan as spending on research, development, sales and expansion increased.
The change illustrates the investment required to move from selling development platforms to producing robots capable of sustained commercial work.
Research and Education Still Dominate Humanoid Demand
Unitree’s shipment numbers provide evidence that there is a real market for humanoid robots, but its customer mix also reveals how early that market remains.
More than 70% of Unitree’s humanoid robot sales during the disclosed period were connected to research and education. Universities, laboratories and development teams use the robots to study locomotion, manipulation, reinforcement learning and embodied AI.
Industrial adoption accounted for a much smaller share.
According to the IPO disclosures, Unitree’s industrial humanoid revenue came mainly from enterprise reception, tour-guiding, intelligent manufacturing and inspection. Reception and tour-guide applications accounted for a substantial part of that category.
This matters because purchasing a robot for experimentation or a public demonstration is different from deploying one as productive equipment.
A commercially successful industrial robot must perform useful work repeatedly, operate safely around people, integrate with existing systems and produce an economic return over an extended service life.
Unitree has demonstrated strong demand for development platforms. The next challenge is proving that its humanoids can move from laboratories and demonstrations into recurring operational roles.
Why the IPO Matters for the Humanoid Robot Industry
The listing could establish one of the first major public-market valuations for a profitable, specialist humanoid robot manufacturer.
Many of the best-known companies developing humanoids remain private or form part of much larger organizations.
Boston Dynamics is controlled by Hyundai Motor Group. Tesla develops Optimus alongside its automotive and energy businesses. Figure AI and 1X Technologies remain privately held.
Unitree would offer investors a more direct way to participate in the development of commercial legged and humanoid robots.
A successful offering could also affect other robotics companies seeking capital.
Strong investor demand would indicate that public markets are willing to fund long-term humanoid development despite uncertainty about when large-scale commercial deployment will arrive. A weak reception could signal concern about valuations, competition and the limited number of proven applications.
The IPO will therefore be watched beyond China.
Its pricing and early trading performance could influence how investors assess companies developing platforms such as Boston Dynamics Atlas, Tesla Optimus, Figure 03 and the 1X NEO.
China Is Accelerating Investment in Embodied AI
Unitree’s IPO arrives as China increases its support for humanoid robotics and embodied artificial intelligence.
The country views robots capable of perceiving and interacting with the physical world as a strategically important technology. National and regional programmes have supported research centres, manufacturing projects, robotics funds and commercial trials.
China also offers a substantial manufacturing ecosystem for motors, batteries, sensors, electronics and precision components.
That supply chain has helped Chinese companies introduce humanoids at comparatively low prices and update their hardware quickly.
Unitree’s approval also comes during a recovery in mainland Chinese listings. Companies raising capital on the Shanghai, Shenzhen and Beijing exchanges collected approximately $7.7 billion during the first half of 2026, an increase of 64.4% from the corresponding period a year earlier.
Regulators nevertheless remain selective, particularly when reviewing companies operating in highly promoted technology sectors.
Unitree’s approval indicates that authorities consider the company sufficiently advanced, commercially established and strategically relevant to move forward under the STAR Market registration system.
Competition Is Becoming More Intense
Unitree may be one of the most commercially visible humanoid manufacturers, but it operates in an increasingly crowded market.
Chinese competitors include UBTech Robotics, AgiBot, Fourier Intelligence, Deep Robotics, Leju Robotics and several younger embodied-AI companies.
Internationally, Unitree must compete with organizations backed by some of the world’s largest technology and manufacturing groups.
Boston Dynamics is developing Atlas with support from Hyundai. Tesla is investing in Optimus. Figure AI has raised substantial private capital, while Apptronik is working with industrial and technology partners on Apollo.
Price competition is also likely to increase as more manufacturers enter the market.
Unitree has historically used affordability as an advantage. However, lower prices can place pressure on margins while increasing the number of robots the company must manufacture, deliver and support.
The company must therefore balance accessibility with the cost of improving hardware, developing AI systems and providing reliable after-sales service.
The Technology Still Has Important Limitations
The IPO does not mean that Unitree has solved the fundamental problems facing general-purpose humanoid robots.
Current machines can perform impressive movements and complete selected tasks under controlled conditions. They still struggle with the flexibility, reliability and contextual understanding that humans use during ordinary physical work.
Dexterous manipulation remains particularly difficult.
A humanoid may be able to walk across a room or reproduce a learned routine while still struggling to identify unfamiliar objects, apply the correct amount of force or recover from unexpected changes.
Battery life, falls, heat management, computing requirements and safety around people also remain important challenges.
Unitree acknowledges that widespread practical adoption will require substantial advances in embodied AI, perception, manipulation and whole-body control. The planned IPO investment is intended to accelerate work in precisely these areas.
What the IPO Could Mean for Unitree Customers
The approval does not immediately change the price or availability of Unitree robots.
Customers will not automatically gain access to new models, and the company has not announced any product-price changes linked directly to the offering.
Over the longer term, the additional capital could help Unitree increase production, develop new products and improve technical support.
A larger manufacturing base may allow the company to deliver more robots and reduce supply constraints. Increased AI investment could support better autonomy, manipulation and task-learning capabilities.
Becoming a publicly listed company would also introduce additional financial disclosure and regulatory obligations.
That transparency could help enterprise buyers assess Unitree’s scale, investment capacity and long-term viability more closely than is normally possible with a privately held robotics manufacturer.
At the same time, public-market expectations can create pressure to maintain rapid growth and launch products quickly. Customers will need to distinguish between demonstrations designed to attract attention and capabilities that are genuinely available in supported commercial systems.
What Happens Next
Unitree must now complete the remaining stages of the offering.
These include determining the final number of shares, establishing an issue price, publishing subscription details and selecting a trading date.
The company and its underwriters will also market the offering to eligible investors before allocating the shares.
The regulatory approval is valid for 12 months, giving Unitree a defined period in which to complete the transaction. No final launch date or price range had been announced when the approval became public.
Until the shares begin trading, Unitree remains a privately controlled company.
Investors and robotics companies will be watching the final valuation closely. It will provide a clearer indication of how financial markets value Unitree’s existing hardware business relative to the longer-term promise of general-purpose humanoid robots.
A Defining Test for Commercial Humanoid Robotics
Unitree’s IPO approval is more than a financing milestone for a single robot manufacturer.
It is a test of whether the commercial progress made by the humanoid robotics industry is strong enough to support a major public listing.
Unitree already has real products, customers, revenue and manufacturing experience. Its growth separates it from companies whose humanoid programmes remain largely experimental.
However, much of its current demand still comes from research, education and demonstrations. Large-scale deployment in factories, warehouses, businesses and homes remains at an early stage.
The proposed $619 million offering gives Unitree an opportunity to close that gap.
The company plans to invest in the robot intelligence, physical platforms, new products and manufacturing infrastructure required to transform its machines from advanced development tools into dependable working systems.
Whether Unitree can make that transition will determine more than the long-term performance of its shares.
It could help establish whether humanoid robots are becoming a sustainable industry—or remain a technically impressive market whose most valuable applications are still waiting to be discovered.
Readers can explore the Unitree G1, review the larger Unitree H2, browse other Unitree robots or compare robot models side by side on Anton Robots.